Clinical Trial Update: Safety and Tolerability of Trametinib in Combination With Docetaxel in Japanese Subjects With Non-small Cell Lung Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the safety and tolerability of trametinib in combination with docetaxel in Japanese patients with non-small cell lung cancer has been…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• MEKINIST (trametinib)
• Taxotere (docetaxel)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Lung Cancer, Non-Small Cell | Phase 1 | Status: WITHDRAWN